stockrowUFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
Follow UFPT
Alert me
UFP Technologies, Inc. (UFPT) Gross margin
UFP Technologies, Inc.'s gross margin over the twelve months to 30 September 2026 was 29.0%, up 0.7 percentage points from fiscal 2025 (28.3%). Over the past ten years it has ranged from 23.7% (fiscal 2016) to 29.1% (fiscal 2024); the current reading is higher than 91% of that period. That is below the Medical Devices industry median of 57.8% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 28.3% | (0.81) |
| FY2024 | 29.1% | 1.03 |
| FY2023 | 28.1% | 2.54 |
| FY2022 | 25.5% | 0.74 |
| FY2021 | 24.8% | (0.14) |
| FY2020 | 24.9% | (2.29) |
| FY2019 | 27.2% | 1.84 |
| FY2018 | 25.4% | 1.36 |
| FY2017 | 24.0% | 0.29 |
| FY2016 | 23.7% | (3.26) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 29.4% | 0.17 |
| Jun 2026 | 29.3% | 0.50 |
| Mar 2026 | 28.8% | 0.59 |
| Dec 2025 | 28.2% | 0.52 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | 86.2% |
| NVCR NovoCure Limited compare | 77.0% |
| AXGN AxoGen, Inc. compare | 74.2% |
| ESTA Establishment Labs Holdings Inc. compare | 70.5% |
| BFLY Butterfly Network, Inc. compare | 70.3% |
| TMDX TransMedics Group, Inc. compare | 58.6% |
| ALMR Alamar Biosciences, Inc. compare | 58.4% |
| NEOG Neogen Corporation compare | 47.4% |
| UFPT UFP Technologies, Inc. | 29.0% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on UFPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement